G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 118 filers reported holding G1 THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,025,000 | -94.6% | 1,000 | -99.9% | 0.06% | -96.0% |
| Q4 2018 | $19,041,000 | -43.1% | 994,287 | +55.2% | 1.55% | -29.0% |
| Q3 2018 | $33,491,000 | +7.0% | 640,481 | -11.0% | 2.18% | -6.0% |
| Q2 2018 | $31,291,000 | +17.3% | 719,985 | 0.0% | 2.32% | +16.5% |
| Q1 2018 | $26,675,000 | +49.8% | 719,985 | -19.8% | 1.99% | +6.7% |
| Q4 2017 | $17,806,000 | -20.3% | 897,505 | 0.0% | 1.86% | -52.7% |
| Q3 2017 | $22,339,000 | +166.9% | 897,505 | +87.0% | 3.94% | +184.1% |
| Q2 2017 | $8,371,000 | – | 479,986 | – | 1.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
| Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
| Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
| 361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
| CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
| Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
| Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
| Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
| HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |